Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.31 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.31 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5961754 | 1.00 | FOLH1 (0.36) | FOLH1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL898887 | 0.83 | PTGS1 (0.36) | FOLH1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL313272 | 0.83 | PTGS1 (0.36) | FOLH1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL4655463 | 0.79 | CYP1A2 (0.45) | FOLH1HDAC1HDAC2GRIK1SLC1A3 | |
| SCHEMBL7701636 | 0.79 | CYP1A2 (0.45) | FOLH1HDAC1HDAC2GRIK1SLC1A3 | |
| SCHEMBL3728136 | 0.78 | CHRM1 (0.33) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL1221384 | 0.76 | ALOX15 (0.45) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL3335954 | 0.76 | ALOX15 (0.45) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL7280578 | 0.76 | FOLH1 (0.40) | FOLH1CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL28243274 | 0.75 | FOLH1 (0.33) | FOLH1CHRM1AKR1A1CHRM3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2151 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11203622-B2 | MASP isoforms as inhibitors of complement activation | OMEROS CORPORATION (US) | 2021-12-21 | — | — | US | claimed |
| EP-2688578-B1 | MIA (MELANOMA INHIBITORY ACTIVITY) INHIBITORS FOR PREVENTING AND CURING VITILIGO | BORDIGNON MATTEO (IT) | 2019-03-27 | — | — | EP | claimed |
| EP-2688578-A2 | MIA (MELANOMA INHIBITORY ACTIVITY) INHIBITORS FOR DETECTING, PREVENTING AND CURING VITILIGO | Bordignon, Matteo (IT) | 2014-01-29 | — | — | EP | claimed |
| US-20140004130-A1 | MIA (Melanoma Inhibitory Activity) Inhibitors for Detecting, Preventing and Curing Vitiligo | BORDIGNON MATTEO (IT) | 2014-01-02 | — | — | US | claimed |
| WO-2012127352-A2 | MIA (MELANOMA INHIBITORY ACTIVITY) INHIBITORS FOR DETECTING, PREVENTING AND CURING VITILIGO | BORDIGNON MATTEO (IT) | 2012-09-27 | — | — | WO | claimed |
| US-20120208774-A1 | METHOD FOR INHIBITING \"MELANOMA INHIBITORY ACTIVITY\" MIA | ANTISENSE PHARMA GMBH (DE) | 2012-08-16 | — | — | US | claimed |
| US-8148493-B2 | Method for inhibiting “melanoma inhibitory activity” MIA | ANTISENSE PHARMA GMBH (DE) | 2012-04-03 | — | — | US | claimed |
| US-20100273705-A1 | Method for inhibiting \"Melanoma Inhibitory Activity\" MIA | ANTISENSE PHARMA GMBH. | 2010-10-28 | — | — | US | claimed |
| US-20060128607-A1 | Method for inhibiting \"melanoma inhibitory activity\" mia | ANTISENSE PHARMA GMBH (DE) | 2006-06-15 | — | — | US | claimed |
| EP-1472279-A1 | A METHOD FOR INHIBITING \"MELANOMA INHIBITORY ACTIVITY\" MIA | Antisense Pharma GmbH (DE) | 2004-11-03 | — | — | EP | claimed |
| WO-2003064457-A1 | A METHOD FOR INHIBITING 'MELANOMA INHIBITORY ACTIVITY' MIA | ANTISENSE PHARMA GMBH (DE) | 2003-08-07 | — | — | WO | claimed |
| US-20260146104-A1 | ANTIBODIES, ACTIVATABLE ANTIBODIES, BISPECIFIC ANTIBODIES, AND BISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USE THEREOF | CYTOMX THERAPEUTICS, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260115317-A1 | GENE THERAPY | IMPERIAL COLLEGE INNOVATIONS LTD (GB) | 2026-04-30 | — | — | US | disclosed |
| EP-3890772-B1 | BOTULINUM TOXIN FOR USE IN THE TREATMENT OF SYMPTOMS OF TRAUMATIC BRAIN INJURY | IPSEN BIOPHARM LTD (GB) | 2026-04-01 | — | — | EP | disclosed |
| US-12589139-B2 | Clostridial neurotoxins comprising an exogenous activation loop | IPSEN BIOPHARM LIMITED (GB) | 2026-03-31 | — | — | US | disclosed |
| WO-1998029422-A1 | CYANOPHOSPHONATE DERIVATIVES | MONSANTO COMPANY (US) | 1998-07-09 | — | — | WO | disclosed |
| WO-1998027210-A1 | COMPOSITIONS AND METHODS FOR STIMULATING PANCREATIC ISLET CELL REGENERATION | ZYMOGENETICS, INC. (US) | 1998-06-25 | — | — | WO | disclosed |
| WO-1998016644-A1 | FIBROBLAST GROWTH FACTOR HOMOLOGS | ZYMOGENETICS, INC. (US) | 1998-04-23 | — | — | WO | disclosed |
| WO-1998016635-A1 | INSULIN HOMOLOGS | ZYMOGENETICS, INC. (US) | 1998-04-23 | — | — | WO | disclosed |
| WO-1998005782-A1 | TESTIS-SPECIFIC INSULIN HOMOLOG POLYPEPTIDES | ZYMOGENETICS, INC. (US) | 1998-02-12 | — | — | WO | disclosed |